CRE REDUCE are proud to deliver another educational and research capacity building activity designed to connect the leaders in the field with relevant clinicians, researchers and industry across the country and abroad.

Outpatient parenteral antimicrobial therapy (OPAT)/Hospital in the Home (HITH) is increasing in popularity and usage globally and the need for information on practices and principles of its use are evident.

We invite you to consider sponsoring our OPAT/HITH Seminar to be held in Sydney on Wednesday February 20 2019.

Benefits of Sponsorship

Sponsors accrue several benefits through this strategic investment:

  • Strengthen the visibility and reputation of the sponsor within higher education
  • Interaction with key researchers involved in optimising the use of antimicrobials in various contexts and who influence research directions
  • Gaining access to clinician-researchers who influence future health practitioners

Three levels of sponsorship are offered:

Silver Sponsor Opportunity

AUD $5, 000

  • Recognition in the Seminar programs
  • Logo presence (one month) on event materials and on the Uni of Queensland administered website
  • Banner at the Seminar
  • Two free corporate registrations

Gold Sponsor Opportunity

AUD $15, 000

  • All of the above
  • Two additional corporate registrations for the seminar
  • One booth in the Seminar registration area
  • Logo presence (two months) on the Seminar website with a hotlink to your organisation's website
  • Ability to sponsor additional Seminar items such as attendee and speaker gifts, audiovisual equipment, programs etc. with proper recognition in all program materials and Seminar website

Platinum Sponsor Opportunity

AUD $30, 000

  • All of the above
  • Five (in total) corporate registrations for the Seminar
  • One special demonstration display area
  • One full-page advertisement in the Seminar program
  • Permanent recognition in the Seminar proceedings
  • Naming rights for the workshop and inclusion of logo on all event materials
  • Logo presence (one year) on our UQ administered website linked to your organisation's website
  • Ability to submit articles of interest in the pre-conference email to attendees
  • Sponsor webpage on the Seminar website with the content delivered by the sponsor to our content management system administrator

Your support as a sponsor is vital to the success of this event and will generate excellent exposure for your company while providing you access to expert health care professionals.

If you would like to discuss this opportunity further, please contact our Centre Manager Mr Nermin Karamujic.

About OPAT/HITH Antimicrobial Seminar



Thank you to all who attended our OPAT/HITH seminar last Wednesday, February 20, at Garvan Institute of Medical Research in Sydney.

There were 105 attendees from a variety of disciplines, including nursing, pharmacy, medicine, microbiology, pharmaceutical industry, publishing as well as policy makers representing NSW State Government.

We are very grateful to the excellent team from Merck Sharp & Dohme (Australia) for their committment to supporting educational activities that promote responsible use of antimicrobials and thereby slow the development of resistance and preserve current therapeutic options. 

Please access the videos of the seminar presentations below.


Seminar presentations videos













Further to our contributions so far in ensuring optimised antimicrobial use, the CRE REDUCE are delivering an important and timely Outpatient parenteral antimicrobial therapy (OPAT)/Hospital in the Home (HITH) Seminar to be hosted in Sydney, Wednesday February 20 2019.

The seminar is organised to precede the Australia Society for Antimicrobials 20th Annual Scientific Meeting in Sydney, held on the 21st - 23rd Feb 

Our practical seminar will aim to provide the latest guidance on all aspects relevant to providing an optimal OPAT/HITH service. We aim to do this in the context of the recent guidelines from the British Society of Antimicrobial Therapy which highlighted  the lack of stability data supporting current practices.

Seminar Program

  • Dr Mark Gilchrist, Imperial College London, UK
  • Dr James Pollard, Barwon Health, Victoria
  • Mr Sean Unwin, Princess Alexandra Hospital, Queensland
  • Dr Kate McCarthy, Royal Brisbane & Women's Hospital, Queensland
  • Ms Pauline Dobson, John Hunter Hospital, New South Wales
  • Prof Jason Roberts, The University of Queensland
  • Mr John Shanks, Royal Darwin Hospital, Northern Territory
  • Dr David Andresen, St Vincent's Hospital, Sydney
  • Mr Tony Lai, The Children's Hospital Westmead, New South Wales
  • Mr Matthew Rawlins, Fiona Stanley Hospital, Western Australia
  • Mr Horst Thiele, Royal North Shore Hospital, New South Wales
  • A/Prof Darren Roberts, St Vincent's Hospital, New South Wales 

OPAT/HITH is increasing in popularity and usage globally and the need for information on practices and principles of its use are evident.

Current trends highlight opportunities for further expansion of scope and mechanisms to provide more convenient and cost-effective care.

Learning Objectives:

  • Understand the role of antimicrobial stewardship for provision of an OPAT service
  • Understand new international recommendations around drug solution-stability characteristics suitable for OPAT
  • Understand how to establish a new or optimise an existing OPAT service
  • Understand the role of dose optimisation within OPAT
  • Understand strengths and weaknesses of different infusor consumables

Target Audience: Infectious Diseases Physicians, Infectious Diseases Pharmacists and Infection Control Pratitioners